Brief: Active Biotech Q2 Operating Loss Widens To SEK 10.1 Mln
Aug 6 (Reuters) - Active Biotech AB (publ) ACTI.ST :
* Q2 OPERATING LOSS SEK 10.1 MILLION VERSUS LOSS SEK 5.4
MILLION
YEAR AGO
* Q2 NET SALES AMOUNTED TO SEK 0.0 M (1.1)
Source text for Eikon: ID:nGNE3dwB6p
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million